Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17[beta]-estradiol in female tumor-bearing spontaneously hypertensive rats
Background Doxorubicin (DOX), an anthracycline therapeutic, is widely used to treat a variety of cancer types and known to induce cardiomyopathy in a time and dose-dependent manner. Postmenopausal and hypertensive females are two high-risk groups for developing adverse effects following DOX treatmen...
Gespeichert in:
Veröffentlicht in: | Biology of sex differences 2018-06, Vol.9 (1) |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!